Author

Katrina I. Paras

Observed name: Katrina Paras

Institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine

Observed institutions: Memorial Sloan Kettering Cancer Center, University of California, Los Angeles, Cornell University, Weill Cornell Medicine

ORCID: 0000-0001-9743-5710

Observed ORCID: 0000-0001-9743-5710

OpenAlex ID: A5086970641

A non-canonical tricarboxylic acid cycle underlies cellular identity

2022 · Paige K. Arnold, Benjamin T. Jackson, et al. · Nature · 302

ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs

2017 · Michael R. Hicks, Julia Hiserodt, et al. · Nature Cell Biology · 200

Amino acid intake strategies define pluripotent cell states

2024 · Pavlina K. Todorova, Benjamin T. Jackson, et al. · Nature Metabolism · 20

Intracellular metabolic gradients dictate dependence on exogenous pyruvate

2025 · Benjamin T. Jackson, Angela M. Montero, et al. · Nature Metabolism · 10

Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle

2026 · Abigail Xie, Julia S. Brunner, et al. · Cell · 8

Aspartate availability drives differential engagement of the malate-aspartate shuttle

2026 · Julia S. Brunner, Anna E. Bridgeman, et al. · Molecular Cell · 8

p53 increases phospholipid headgroup scavenging in senescence

2026 · Jossie J. Yashinskie, Xianbing Zhu, et al. · Nature Cell Biology · 7

PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al. · Cancer Research · 4

Supplementary Figure 2 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Table 1 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Figure 4 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Figure 5 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Figure 3 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Figure 7 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Figure 6 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Figure 1 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Table 3 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Supplementary Table 2 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Data from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma

2025 · Katrina I. Paras, Julia S. Brunner, et al.

Works count: 19

Citation count: 559

H-index: 7

I10-index: 4